FDA Approves Expanded Generalized Pustular Psoriasis Indications for Spevigo

Ingelheim, Germany, March 19, 2024 -- Boehringer Ingelheim today announced that the US Food and Drug Administration (FDA) has approved Spevigo (spesolimab-sbzo) injection for the treatment of generalized pustular psoriasis (GPP) in adults and...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news